TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice.

MLA

Hamad, Samera H., et al. “TP53, CDKN2A/P16, and NFE2L2/NRF2 Regulate the Incidence of Pure- and Combined-Small Cell Lung Cancer in Mice.” Oncogene, vol. 41, no. 25, June 2022, pp. 3423–32. EBSCOhost, https://doi.org/10.1038/s41388-022-02348-0.

APA

Hamad, S. H., Montgomery, S. A., Simon, J. M., Bowman, B. M., Spainhower, K. B., Murphy, R. M., Knudsen, E. S., Fenton, S. E., Randell, S. H., Holt, J. R., Hayes, D. N., Witkiewicz, A. K., Oliver, T. G., Major, M. B., & Weissman, B. E. (2022). TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice. Oncogene, 41(25), 3423–3432. https://doi.org/10.1038/s41388-022-02348-0

Chicago

Hamad, Samera H, Stephanie A Montgomery, Jeremy M Simon, Brittany M Bowman, Kyle B Spainhower, Ryan M Murphy, Erik S Knudsen, et al. 2022. “TP53, CDKN2A/P16, and NFE2L2/NRF2 Regulate the Incidence of Pure- and Combined-Small Cell Lung Cancer in Mice.” Oncogene 41 (25): 3423–32. doi:10.1038/s41388-022-02348-0.